SCHEMBL4649306

SCHEMBL4649306

CCOC(=O)c1cc2c(N)ccc(Cl)c2n1Cc1cccc(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MEN1 O00255 1/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51
F10 P00742 3/20 0.48
MAPT P10636 4/20 0.45
KDM4E B2RXH2 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPK1 P28482 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CCR2 P41597 1/20 0.43
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.43
ATM Q13315 1/20 0.43
PLA2G2A P14555 3/20 0.43
NOD2 Q9HC29 1/20 0.43
NOD1 Q9Y239 1/20 0.43
ALOX5 P09917 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653186 0.92 KMT2A (0.51) KMT2ASMN1; SMN2MEN1LMNAHPGD
SCHEMBL4649686 0.91 KMT2A (0.50) KMT2ASMN1; SMN2MEN1LMNAHPGD
SCHEMBL4650163 0.90 KMT2A (0.49) KMT2ASMN1; SMN2MEN1LMNAHPGD
SCHEMBL4653221 0.85 F10 (0.59) KMT2ASMN1; SMN2MEN1LMNAHPGD
SCHEMBL6302415 0.79 MAPT (0.51) SMN1; SMN2LMNAF10MAPTKDM4E
SCHEMBL6306975 0.78 CCR2 (0.72) SMN1; SMN2LMNAF10MAPTKDM4E
SCHEMBL4653080 0.76 F10 (0.45) KMT2ASMN1; SMN2MEN1LMNAHPGD
SCHEMBL6358543 0.76 F10 (0.61) KMT2ASMN1; SMN2MEN1LMNAF10
SCHEMBL4650061 0.75 KMT2A (0.44) KMT2ASMN1; SMN2MEN1LMNAHPGD
SCHEMBL6307843 0.75 NOD2 (0.74) KMT2ASMN1; SMN2MEN1F10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904487-A2 INDOLE DERIVATIVES FOR THE TREATMENT OF TUBERCULOSIS AstraZeneca AB (SE) 2008-04-02 EP disclosed
WO-2006067392-A2 INDOLE DERIVATIVES FOR THE TREATMENT OF TUBERCULOSIS ASTRAZENECA AB (SE) 2006-06-29 WO disclosed